MedTrace Logo

The Safety and Efficacy of SeQuent® Please in Real World Chinese Coronary Instent Restenosis Patients

NCT03624205 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 520

Last updated 2018-08-10

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of paclitaxel -eluting PTCA- balloon (SeQuent® Please) in real world Chinese Coronary In Sentrestenosis patients

Conditions

  • Coronary In Sentrestenosis

Interventions

DEVICE

paclitaxel-releasing coronary balloon (SeQuent® Please)

SeQuent® Please with a length of 10mm,15mm,17mm,20mm and 26mm and diameter of 2.5 mm, 2.75 mm, 3.0mm, 3.5mm and 4.0mm are to be used in the trial

Sponsors & Collaborators

  • B. Braun Medical International Trading Company Ltd.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-24
Primary Completion
2022-01-01
Completion
2022-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03624205 on ClinicalTrials.gov